Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].
CAMBRIDGE, MA, October 22, 2020 – A premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences (“Bain Capital”), and RA Capital Management (“RA Capital”) (collectively the “Investor Group”) together with Sarepta Therapeutics, Inc. (“Sarepta”) (NASDAQ: SRPT), a leader in precision genetic medicine for rare diseases, today announced a...
BOSTON, MA, October 21, 2020 - BCLS Acquisition Corp. (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities, today announced the pricing of its initial public offering of 12,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares will be listed on the Nasdaq...
BOSTON-- May 20, 2020 – Atea Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections, today announced a $215 million Series D financing. The financing was led by Bain Capital Life Sciences and also included new investors RA Capital Management, Perceptive Advisors, Rock Springs Capital, Adage...
IRVINE, California-JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences. Additional participants in the financing included existing investors Andera Partners, Gimv, Legend...
Emeryville, CA., August 12, 2019 – Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today announced Andrew A. F. Hack, M.D., Ph.D., a Managing Director at Bain Capital Life Sciences, has been appointed to Dynavax’s Board of Directors. The appointment follows an investment by Bain Capital Life Sciences in Dynavax’s...
SOUTH SAN FRANCISCO, CA, December 19, 2018 - Annexon Biosciences, a clinical stage biopharmaceutical company focused on the development of novel therapeutics through inhibition of the classical complement pathway, today announced that it has closed a $75 million Series C financing. The financing was led by new investor Bain Capital Life Sciences, with participation by Surveyor Capital (a Citadel...
SAN DIEGO, November 29, 2018 – ViaCyte, Inc., a privately-held clinical stage regenerative medicine company, today announced an $80 million Series D financing led by Bain Capital Life Sciences and joined by TPG and RA Capital Management, as well as existing investor, Sanderling Ventures, and several individual supporters of the Company. Proceeds from the financing will be used to further...
BOSTON and NEW YORK, October 23, 2018 – Bain Capital, LP and Pfizer Inc. (NYSE: PFE) today announced the creation of Cerevel Therapeutics, LLC (“Cerevel”), a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). Pfizer is contributing a portfolio of pre-commercial neuroscience assets to Cerevel, which include three...
LOWELL, MA, May 2, 2018 – Rapid Micro Biosystems, the leading provider of automated, growth-based, rapid microbial detection technology for the healthcare product manufacturing sector, announced that it has secured $60 million in equity financing led by new investors Bain Capital Life Sciences and Xeraya Capital. The new funding round also includes a commitment from another new investor, Asahi...
EVANSTON, ILLINOIS, December 18, 2017 – Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today is announcing the completion of a $70 million Series B financing to fund advancement of its expanding clinical-stage pipeline. The financing was led by Bain Capital Life Sciences. Additional new investors include Adage...
#BainCapitalPrivateEquity is thrilled to invest in the growth of CNI Group subsidiary #Maxford, a global leader in… https://t.co/OqsH6tqoSR
Happy #PrideMonth – We are honored to join forces with @OutLeadership, the largest coalition of global companies wo… https://t.co/Tgz51VlN1O
#BainCapitalCredit is excited to invest in broadband technology provider @Surf_Broadband to bring the company’s fib… https://t.co/dOl94Fn8tN
The #PMC2021 fundraising goal is $52 million. Learn more and register today. https://t.co/tsNP5lTKgg
Register to attend the virtual @CityYearBoston graduation this Friday. Details below. https://t.co/2hrH9UqxCB
Learn more about the @DanaFarber Defy Cancer campaign on @TheJimmyFund blog. https://t.co/IDumDeTebt
Amid a historic rise in advanced ransomware attacks, #BainCapitalPrivateEquity is proud to partner with… https://t.co/vjyJTBVmHL
Read the "3 Must Have Elements to Scale with Impact" from the @GreenLight_Fund. https://t.co/D06gQAevIK
Read how @CityYear was able to quickly pivot to serve the local Memphis community during the start of the COVID-19… https://t.co/k5qx6TOXYo
Proud to share that #BainCapitalTechOpportunities’ inaugural investment and partner company @acloudguru has entered… https://t.co/fYH0wcSvvZ